Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MTS Eravacycline 0.002 - 32 µg/mL

K-Number: K182557 · 2018-11-02

Decision Date2018-11-02
Product CodeJWY
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

MTS Eravacycline 0.002 - 32 µg/mL is a medical device manufactured by Liofilchem s.r.l.. It received FDA 510(k) clearance on 2018-11-02 under approval number K182557. The device is classified under product code JWY. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MTS Eravacycline 0.002 - 32 µg/mL?

MTS Eravacycline 0.002 - 32 µg/mL is a medical device that received FDA 510(k) clearance on 2018-11-02. It is manufactured by Liofilchem s.r.l.. The 510(k) number is K182557.

When was MTS Eravacycline 0.002 - 32 µg/mL approved by the FDA?

MTS Eravacycline 0.002 - 32 µg/mL received FDA 510(k) clearance on 2018-11-02, under approval number K182557.

What company makes MTS Eravacycline 0.002 - 32 µg/mL?

MTS Eravacycline 0.002 - 32 µg/mL is manufactured by Liofilchem s.r.l..

What is the FDA product code for MTS Eravacycline 0.002 - 32 µg/mL?

The FDA product code for MTS Eravacycline 0.002 - 32 µg/mL is JWY.

Other Devices by Liofilchem s.r.l.

View all 35 devices →

Related Devices (Code: JWY)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.